Targeting a neoantigen derived from a common TP53 mutation.
Science. 2021 Mar 5;371(6533):eabc8697. doi: 10.1126/science.abc8697. Epub 2021 Mar 1.
Science. 2021.
PMID: 33649166
Free PMC article.